Newborn screening and gene therapy in SMA: Challenges related to vaccinations.

Kotulska, Katarzyna; Jozwiak, Sergiusz; Jedrzejowska, Maria; Gos, Monika; Ogrodnik, Magdalena; Wysocki, Jacek; Czajka, Hanna; Kuchar, Ernest

Kotulska, Katarzyna; Jozwiak, Sergiusz; Jedrzejowska, Maria; Gos, Monika; Ogrodnik, Magdalena; Wysocki, Jacek; Czajka, Hanna; Kuchar, Ernest.

Afiliación

Kotulska K; Department of Neurology and Epileptology, The Children's Memorial Health Institute, Warsaw, Poland.
Jozwiak S; Research Department, The Children's Memorial Health Institute, Warsaw, Poland.
Jedrzejowska M; Department of Neurology, Medical University of Warsaw, Warsaw, Poland.
Gos M; Department of Medical Genetics, Institute of Mother and Child, Warsaw, Poland.
Ogrodnik M; Department of Neurology and Epileptology, The Children's Memorial Health Institute, Warsaw, Poland.
Wysocki J; Department of Preventive Medicine, Poznan University of Medical Sciences, Poznan, Poland.
Czajka H; Pediatric Department, Rzeszów University, Rzeszów, Poland.
Kuchar E; Department of Pediatrics with Clinical Assessment Unit, Medical University of Warsaw, Warsaw, Poland.

Front Neurol ; 13: 890860, 2022.

Article en En | MEDLINE | ID: mdl-36504644

Palabras clave

gene therapy; newborn screening; onasemnogene abeparvovec; spinal muscular atrophy; vaccinations

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Guideline / Screening_studies Idioma: En Revista: Front Neurol Año: 2022 Tipo del documento: Article País de afiliación: Polonia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google